Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial
This study evaluates the effectiveness, safety and cost-effectiveness of VNPs (pod and tank device) compared with nicotine replacement therapy ([NRT] —gum or lozenge) for smoking cessation.MethodsThis is a two-arm, open-label, superiority, parallel group, randomized controlled trial (RCT) with allocation concealment and blinded outcome assessment. The RCT is conducted at the National Drug and Alcohol Research Centre at the University of New South Wales, Sydney, Australia. Participants are people who smoke daily, are interested in quitting and receive a government pension or allowance (N = 1058). Participants will be rand...
Source: Trials - September 14, 2022 Category: Research Source Type: clinical trials
Study protocol for a multi-center RCT testing a group-based parenting intervention tailored to mothers with borderline personality disorder against a waiting control group (ProChild*-SP1)
This study aims to evaluate this first disorder-specific parenting intervention for BPD in a randomized controlled trial.MethodIn a parallel-group, two-arm, randomized controlled trial, an initialN = 178 mothers diagnosed with BPD and their children aged 6 months to 6 years are assigned to either the parenting intervention or a waiting control group. If taking place, participants of both groups continue their regular treatment for BPD diagnosis (e.g., individual therapy, medication). Th e primary outcomes are changes in parenting from baseline (day 0) to post intervention (week 12) and follow-up (6 months after grou...
Source: Trials - July 23, 2022 Category: Research Source Type: clinical trials
Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction
Condition: Myocardial Infarction Type 2 Interventions: Diagnostic Test: Coronary computed tomography angiography; Diagnostic Test: Invasive coronary angiography; Diagnostic Test: Transthoracic echocardiography; Diagnostic Test: Cardiac MRI scan; Drug: Antiplatelet Drug (Aspirin or Statin); Drug: Anticoagulants (Apixaba n, Edoxaban, Rivaroxoban, Warfarin); Drug: Guideline directed heart failure therapy; Drug: Statins (Cardiovascular Agents) Sponsors: University of Edinburgh; Chief Scientist Office of the Scottish Government Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2022 Category: Research Source Type: clinical trials
STEP-COVID: A Program for Pregnant Women During the SARS-CoV-2 Pandemic
Conditions: Psychological; Mental Health Issue; Prenatal Stress; Maternal Distress; COVID-19 Pandemic Intervention: Behavioral: STEP-COVID Sponsors: Université du Québec à Trois-Rivières; Public Health Agency of Canada (PHAC); Canada Research Chairs Endowment of the Federal Government of Canada Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2022 Category: Research Source Type: clinical trials
Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction
Condition: Myocardial Infarction Type 2 Interventions: Diagnostic Test: Coronary computed tomography angiography; Diagnostic Test: Invasive coronary angiography; Diagnostic Test: Transthoracic echocardiography; Diagnostic Test: Cardiac MRI scan; Drug: Antiplatelet Drug (Aspirin or Statin); Drug: Anticoagulants (Apixaba n, Edoxaban, Rivaroxoban, Warfarin); Drug: Guideline directed heart failure therapy; Drug: Statins (Cardiovascular Agents) Sponsors: University of Edinburgh; Chief Scientist Office of the Scottish Government Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2022 Category: Research Source Type: clinical trials
STEP-COVID: A Program for Pregnant Women During the SARS-CoV-2 Pandemic
Conditions: Psychological; Mental Health Issue; Prenatal Stress; Maternal Distress; COVID-19 Pandemic Intervention: Behavioral: STEP-COVID Sponsors: Université du Québec à Trois-Rivières; Public Health Agency of Canada (PHAC); Canada Research Chairs Endowment of the Federal Government of Canada Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2022 Category: Research Source Type: clinical trials
Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction
Condition: Myocardial Infarction Type 2 Interventions: Diagnostic Test: Coronary computed tomography angiography; Diagnostic Test: Invasive coronary angiography; Diagnostic Test: Transthoracic echocardiography; Diagnostic Test: Cardiac MRI scan; Drug: Antiplatelet Drug (Aspirin or Statin); Drug: Anticoagulants (Apixaba n, Edoxaban, Rivaroxoban, Warfarin); Drug: Guideline directed heart failure therapy; Drug: Statins (Cardiovascular Agents) Sponsors: University of Edinburgh; Chief Scientist Office of the Scottish Government Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2022 Category: Research Source Type: clinical trials
STEP-COVID: A Program for Pregnant Women During the SARS-CoV-2 Pandemic
Conditions: Psychological; Mental Health Issue; Prenatal Stress; Maternal Distress; COVID-19 Pandemic Intervention: Behavioral: STEP-COVID Sponsors: Université du Québec à Trois-Rivières; Public Health Agency of Canada (PHAC); Canada Research Chairs Endowment of the Federal Government of Canada Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2022 Category: Research Source Type: clinical trials
Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction
Condition: Myocardial Infarction Type 2 Interventions: Diagnostic Test: Coronary computed tomography angiography; Diagnostic Test: Invasive coronary angiography; Diagnostic Test: Transthoracic echocardiography; Diagnostic Test: Cardiac MRI scan; Drug: Antiplatelet Drug (Aspirin or Statin); Drug: Anticoagulants (Apixaba n, Edoxaban, Rivaroxoban, Warfarin); Drug: Guideline directed heart failure therapy; Drug: Statins (Cardiovascular Agents) Sponsors: University of Edinburgh; Chief Scientist Office of the Scottish Government Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2022 Category: Research Source Type: clinical trials
STEP-COVID: A Program for Pregnant Women During the SARS-CoV-2 Pandemic
Conditions: Psychological; Mental Health Issue; Prenatal Stress; Maternal Distress; COVID-19 Pandemic Intervention: Behavioral: STEP-COVID Sponsors: Université du Québec à Trois-Rivières; Public Health Agency of Canada (PHAC); Canada Research Chairs Endowment of the Federal Government of Canada Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2022 Category: Research Source Type: clinical trials
Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction
Condition: Myocardial Infarction Type 2 Interventions: Diagnostic Test: Coronary computed tomography angiography; Diagnostic Test: Invasive coronary angiography; Diagnostic Test: Transthoracic echocardiography; Diagnostic Test: Cardiac MRI scan; Drug: Antiplatelet Drug (Aspirin or Statin); Drug: Anticoagulants (Apixaba n, Edoxaban, Rivaroxoban, Warfarin); Drug: Guideline directed heart failure therapy; Drug: Statins (Cardiovascular Agents) Sponsors: University of Edinburgh; Chief Scientist Office of the Scottish Government Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2022 Category: Research Source Type: clinical trials
STEP-COVID: A Program for Pregnant Women During the SARS-CoV-2 Pandemic
Conditions: Psychological; Mental Health Issue; Prenatal Stress; Maternal Distress; COVID-19 Pandemic Intervention: Behavioral: STEP-COVID Sponsors: Université du Québec à Trois-Rivières; Public Health Agency of Canada (PHAC); Canada Research Chairs Endowment of the Federal Government of Canada Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2022 Category: Research Source Type: clinical trials
Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction
Condition: Myocardial Infarction Type 2 Interventions: Diagnostic Test: Coronary computed tomography angiography; Diagnostic Test: Invasive coronary angiography; Diagnostic Test: Transthoracic echocardiography; Diagnostic Test: Cardiac MRI scan; Drug: Antiplatelet Drug (Aspirin or Statin); Drug: Anticoagulants (Apixaba n, Edoxaban, Rivaroxoban, Warfarin); Drug: Guideline directed heart failure therapy; Drug: Statins (Cardiovascular Agents) Sponsors: University of Edinburgh; Chief Scientist Office of the Scottish Government Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2022 Category: Research Source Type: clinical trials
STEP-COVID: A Program for Pregnant Women During the SARS-CoV-2 Pandemic
Conditions: Psychological; Mental Health Issue; Prenatal Stress; Maternal Distress; COVID-19 Pandemic Intervention: Behavioral: STEP-COVID Sponsors: Université du Québec à Trois-Rivières; Public Health Agency of Canada (PHAC); Canada Research Chairs Endowment of the Federal Government of Canada Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2022 Category: Research Source Type: clinical trials
